EU MSC2 2015: Contributing to MSC Knowledge-Sharing, Research & Development

Our sister project REDDSTAR and Leiden University Medical Center are co-organizing EU MSC²2015, a meeting in Leiden, NL on September 7^th and 8^th to bring together nine EU-funded, mesenchymal stromal cell-focussed consortia. Projects include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2. This two day, interactive meeting will be held at the Stadsgehoorzaal Leiden.

The objectives of the meeting are to:

Enhance knowledge-sharing between EU research groups working in the mesenchymal stromal cell biology domain
Engage with European Commission Project Officers and other stakeholders from International Society of Cellular Therapy, stem cell ethicists and the European Medicines Agency (EMA)
Assemble trans-disciplinary research groups working across the global health spectrum but with a common focus of mesenchymal stromal cell biology
Bring up-and-coming researchers together for networking purposes, and to explore future consortium building and international funding application opportunities

Expected impacts and outcomes:

Provide opportunities to develop new mesenchymal stromal cell networks
Disseminate the findings and challenges between MSC-focussed consortia
Improve the communication potential of research, outcomes and the value of the research
Explore potential for new commercial technologies
Collectively enhance the quality and impact of planned clinical trials

These EU projects are:

For more information, please visit EU MSC²2015 and register via Eventbrite.

Danielle Nicholson, Orbsen Therapeutics, NUI Galway and Brigitte Wieles, Project Manager LUMC